On January 5, 2026, GE HealthCare Technologies Inc. received an unsolicited mini-tender proposal from Potemkin Limited to purchase up to 100,000 shares of GE HealthCare common stock at $54.20 per share in cash. GE HealthCare’s board and management have recommended that shareholders decline the offer, noting that the bid price is approximately 34.8% below the company’s closing market price of $83.09 on the date prior to receipt of the offer. Management warned that accepting the mini-tender could expose shareholders to execution risk, limited liquidity and potential regulatory uncertainties associated with offers for small blocks of stock. GE HealthCare plans to communicate directly with retail investors via email and its shareholder website to ensure holders understand the significant discount and potential pitfalls of this unsolicited proposal.

At CES 2026 in Las Vegas, GE HealthCare announced a collaboration with NXP Semiconductors to develop and showcase two edge AI concepts for operating rooms and neonatal intensive care units. The first concept employs on-device voice-command integration for anesthesia delivery, aiming to reduce cognitive load and alarm fatigue by enabling hands-free interaction with ventilators and infusion pumps. The second concept uses real-time image analysis on a dedicated neural processing unit to monitor infant position, detect crying and identify hazardous objects in the NICU, with all data processed locally to maintain patient privacy. Both prototypes leverage NXP’s eIQ AI Toolkit and GE HealthCare’s Responsible AI framework—emphasizing safety, explainability and data security—and mark initial steps toward embedding low-latency intelligence at the point of care. GE HealthCare and NXP will demonstrate the solutions at NXP’s Central Plaza Pavilion #134 throughout the show.